Informations générales (source: ClinicalTrials.gov)

NCT02829788 Statut inconnu
Study Comparing the Role of the Laparoscopy Surgical Staging in the Peritoneal Carcinomatosis to Laparotomic Approach (COELIOCHIP)
Observational
  • Carcinomes
  • Tumeurs du péritoine
Hospices Civils de Lyon (Voir sur ClinicalTrials)
novembre 2015
décembre 2017
29 juin 2024
The peritoneum is the second most common site of recurrence in patients with colorectal cancer. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy improve the prognosis of these patients and incorporates surgical removal of all visible disease followed by chemical destruction of microscopic disease through chemoperfusion. The most validated predictors of outcome are preoperative tumor burden measured in terms of the peritoneal carcinomatosis index (PCI) and completeness of cytoreduction (CC score). Diagnostic laparoscopy prior to resection is widely used in hepatopancreaticobiliary and colorectal cancer and has been shown to be effective in excluding unnecessary laparotomy associated with higher morbidity.
 Voir le détail

Etablissements

Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
Hospices Civils de Lyon - Centre Hospitalier Lyon Sud Service de Chirurgie Générale et Digestive - 165 chemin du grand Revoyet - 69495 - Pierre-benite - France Olivier GLEHEN, Prof En recrutement Contact (sur clinicalTrials)

Critères

Tous
Inclusion Criteria:

- Patients with Colorectal cancer with a resected minimal synchronous peritoneal
carcinomatosis, or ovarian metastases, tumour rupture in the abdominal cavity.

- Patients received six months of systemic chemotherapy (currently the Folfox-4
regimen which could be modified if the standard is modified)


- None